Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10002038HBVENSG00000166411.14protein_codingIDH3ANoNo3419P50213
TVIS10023262HBVENSG00000166411.14protein_codingIDH3ANoNo3419P50213
TVIS10027409HBVENSG00000166411.14protein_codingIDH3ANoNo3419P50213
TVIS30004524HIVENSG00000166411.14protein_codingIDH3ANoNo3419P50213
TVIS30039100HIVENSG00000166411.14protein_codingIDH3ANoNo3419P50213
TVIS30039101HIVENSG00000166411.14protein_codingIDH3ANoNo3419P50213
TVIS30039102HIVENSG00000166411.14protein_codingIDH3ANoNo3419P50213
TVIS30039103HIVENSG00000166411.14protein_codingIDH3ANoNo3419P50213
TVIS44029290HTLV-1ENSG00000166411.14protein_codingIDH3ANoNo3419P50213
TVIS44003209HTLV-1ENSG00000166411.14protein_codingIDH3ANoNo3419P50213
TCGA Plot Options
Drug Information
GeneIDH3A
DrugBank IDDB00157
Drug NameNADH
Target IDBE0000011
UniProt IDP50213
Regulation Type
PubMed IDs17139284; 17016423; 13152105; 4292141; 4380379
CitationsOverington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@PLAUT GW, SUNG SC: Diphosphopyridine nucleotide isocitric dehydrogenase from animal tissues. J Biol Chem. 1954 Mar;207(1):305-14.@@Stein AM, Stein JH, Kirkman SK: Diphosphopyridine nucleotide specific isocitric dehydrogenase of mammalian mitochondria. I. On the roles of pyridine nucleotide transhydrogenase and the isocitric dehydrogenases in the respiration of mitochondria of normal and neoplastic tissues. Biochemistry. 1967 May;6(5):1370-9.@@Rose ZB: The stereochemistry of the nicotinamide adenine dinucleotide-specific isocitric dehydrogenase reaction. J Biol Chem. 1966 May 25;241(10):2311-3.
GroupsApproved; Nutraceutical
Direct Classification(5'->5')-dinucleotides
SMILESNC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O
PathwaysEthylmalonic Encephalopathy; 3-Methylglutaconic Aciduria Type III; Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCAD Deficiency); Caffeine Metabolism; Fructose and Mannose Degradation; Isovaleric Aciduria; Lysine Degradation; Methylmalonic Aciduria Due to Cobalamin-Related Disorders; Glycerol Phosphate Shuttle; Zellweger Syndrome; Propionic Acidemia; Glycolysis; Xanthine Dehydrogenase Deficiency (Xanthinuria); S-Adenosylhomocysteine (SAH) Hydrolase Deficiency; Tryptophan Metabolism; Glutaric Aciduria Type I; 3-Methylcrotonyl-CoA Carboxylase Deficiency Type I; Glycine N-Methyltransferase Deficiency; Dimethylglycine Dehydrogenase Deficiency; Androgen and Estrogen Metabolism; Nucleotide Sugars Metabolism; 3-Methylglutaconic Aciduria Type IV; Dihydropyrimidine Dehydrogenase Deficiency (DHPD); Malate-Aspartate Shuttle; Folate Metabolism; Valine, Leucine, and Isoleucine Degradation; Maple Syrup Urine Disease; Glycerol Kinase Deficiency; Adenylosuccinate Lyase Deficiency; Cysteine Metabolism
PharmGKBPA164755085
ChEMBLCHEMBL1234616